ACE BioSciences A/S Divests Its Fast-Track Protein Identification Subsidiary, Alphalyse, In Management Buyout
10/19/2005 5:13:21 PM
ACE BioSciences A/S, the infectious diseases company, has divested Alphalyse A/S, its wholly owned, fast track protein identification subsidiary, in a management buy-out. Under the terms of the agreement, three members of staff will leave ACE BioSciences to join Alphalyse. They include Dr Thomas Kofoed, formerly Head of Protein Identification at ACE BioSciences and Chief Operating Officer of Alphalyse, who will be Chief Executive Officer of the newly independent entity. Financial details were not disclosed.
comments powered by